BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND SOX2, MGC2413, 6657, ENSG00000181449, MCOPS3, P48431, ANOP3
288 results:

  • 1. STIM1/sox2 proteins are co-expressed in the tumor and microenvironmental stromal cells of pancreatic ductal adenocarcinoma and ampullary carcinoma.
    Sweed D; Elhamed SMA; Aiad HAS; Ehsan NA; Hemida AS; Dawoud MM
    World J Surg Oncol; 2024 Mar; 22(1):84. PubMed ID: 38532463
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A novel DDIT3 activator dehydroevodiamine effectively inhibits tumor growth and tumor cell stemness in pancreatic cancer.
    Zhu SL; Qi M; Chen MT; Lin JP; Huang HF; Deng LJ; Zhou XW
    Phytomedicine; 2024 Jun; 128():155377. PubMed ID: 38503154
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Essential role of PLD2 in hypoxia-induced stemness and therapy resistance in ovarian tumors.
    Muñoz-Galván S; Verdugo-Sivianes EM; Santos-Pereira JM; Estevez-García P; Carnero A
    J Exp Clin Cancer Res; 2024 Feb; 43(1):57. PubMed ID: 38403587
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. cancer-associated fibroblasts promote stemness maintenance and gemcitabine resistance via HIF-1α/miR-21 axis under hypoxic conditions in pancreatic cancer.
    Deng K; Zou F; Xu J; Xu D; Luo Z
    Mol Carcinog; 2024 Mar; 63(3):524-537. PubMed ID: 38197482
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting sox2/MYC signaling and restoring chemosensitivity.
    Zheng Q; Tang J; Aicher A; Bou Kheir T; Sabanovic B; Ananthanarayanan P; Reina C; Chen M; Gu JM; He B; Alcala S; Behrens D; Lawlo RT; Scarpa A; Hidalgo M; Sainz B; Sancho P; Heeschen C
    J Exp Clin Cancer Res; 2023 Nov; 42(1):323. PubMed ID: 38012687
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. E3 ubiquitin ligase RNF180 impairs IPO4/sox2 complex stability and inhibits sox2-mediated malignancy in ovarian cancer.
    Zhao H; Bi F; Li M; Diao Y; Zhang C
    Cell Signal; 2024 Jan; 113():110961. PubMed ID: 37923100
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Scoulerine promotes cytotoxicity and attenuates stemness in ovarian cancer by targeting PI3K/AKT/mTOR axis.
    Wang F; Zhang Y; Pang R; Shi S; Wang R
    Acta Pharm; 2023 Sep; 73(3):475-488. PubMed ID: 37708956
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Vemurafenib activates the sonic hedgehog pathway and promotes thyroid cancer stem cell self-renewal.
    Lu Y; Zhao Y; Liu P; Xu X
    Endocr Relat Cancer; 2023 Nov; 30(11):. PubMed ID: 37643458
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Biomimetic Microenvironmental Stiffness Boosts Stemness of Pancreatic Ductal Adenocarcinoma via Augmented Autophagy.
    Gong T; Wu D; Pan H; Sun Z; Yao X; Wang D; Huang Y; Li X; Guo Y; Lu Y
    ACS Biomater Sci Eng; 2023 Sep; 9(9):5347-5360. PubMed ID: 37561610
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Umbelliprenin induces autophagy and apoptosis while inhibits cancer cell stemness in pancreatic cancer cells.
    Wang H; Liu Y; Wang Y; Xu T; Xia G; Huang X
    Cancer Med; 2023 Jul; 12(14):15277-15288. PubMed ID: 37409635
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Clinicopathological analysis of pseudostratified ependymal tubules in ovarian mature teratoma].
    Xiao XL; Huang YX; Chen JM; Liu SG; Mo RM; Lai LZ
    Zhonghua Bing Li Xue Za Zhi; 2023 Jul; 52(7):678-682. PubMed ID: 37408397
    [No Abstract]    [Full Text] [Related]  

  • 12. Primary Ovarian Small Cell Carcinoma of Pulmonary Type: Analysis of 6 Cases and Review of 31 Cases in the Literatures.
    Chen X; Liu HL; Wang JS; Zhao FH
    Chin Med Sci J; 2023 Jun; 38(2):130-137. PubMed ID: 37286512
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Evaluating the biological effectiveness of boron neutron capture therapy by using microfluidics-based pancreatic tumor spheroids.
    Yu LY; Hsu CH; Li CY; Hong SY; Chen CR; Chen CS
    Analyst; 2023 Jun; 148(13):3045-3056. PubMed ID: 37272284
    [No Abstract]    [Full Text] [Related]  

  • 14. METTL3 promotes pancreatic cancer proliferation and stemness by increasing stability of ID2 mRNA in a m6A-dependent manner.
    Chen J; Zhang H; Xiu C; Gao C; Wu S; Bai J; Shen Q; Yin T
    Cancer Lett; 2023 Jul; 565():216222. PubMed ID: 37196908
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Screening and Identification of a Prognostic Model of Ovarian cancer by Combination of Transcriptomic and Proteomic Data.
    Jiang J; Chen Z; Wang H; Wang Y; Zheng J; Guo Y; Jiang Y; Mo Z
    Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189432
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis.
    Zhou T; Xie Y; Hou X; Bai W; Li X; Liu Z; Man Q; Sun J; Fu D; Yan J; Zhang Z; Wang Y; Wang H; Jiang W; Gao S; Zhao T; Chang A; Wang X; Sun H; Zhang X; Yang S; Huang C; Hao J; Liu J
    J Exp Clin Cancer Res; 2023 May; 42(1):111. PubMed ID: 37143164
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Regulation of self-renewal in ovarian cancer stem cells by fructose via chaperone-mediated autophagy.
    Sohn EJ; Kim JH; Oh SO; Kim JY
    Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166723. PubMed ID: 37087023
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Low-dose BPA and its substitute BPS promote ovarian cancer cell stemness via a non-canonical PINK1/p53 mitophagic signaling.
    Yuan X; Chen K; Zheng F; Xu S; Li Y; Wang Y; Ni H; Wang F; Cui Z; Qin Y; Xia D; Wu Y
    J Hazard Mater; 2023 Jun; 452():131288. PubMed ID: 36989771
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Reactivated thyroid hormone receptor β attenuates anaplastic thyroid cancer (ATC) stem cell activity.
    Zhu X; Zhao L; Doolittle WKL; Cheng SY
    Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36939877
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Characterization of immature ovarian teratomas through single-cell transcriptome.
    Cao M; Deng Y; Deng Y; Wu J; Yang C; Wang Z; Hou Q; Fu H; Ren Z; Xia X; Li Y; Wang W; Xu H; Liao X; Shu Y
    Front Immunol; 2023; 14():1131814. PubMed ID: 36936909
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 15.